Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.
about
Hyaluronan (HA) interacting proteins RHAMM and hyaluronidase impact prostate cancer cell behavior and invadopodia formation in 3D HA-based hydrogelsThe mechanism of growth-inhibitory effect of DOC-2/DAB2 in prostate cancer. Characterization of a novel GTPase-activating protein associated with N-terminal domain of DOC-2/DAB2Near IR heptamethine cyanine dye-mediated cancer imagingSox2 is an androgen receptor-repressed gene that promotes castration-resistant prostate cancerHOXB13 is downregulated in colorectal cancer to confer TCF4-mediated transactivationMolecular classification of prostate cancer progression: foundation for marker-driven treatment of prostate cancerAutomated whole animal bio-imaging assay for human cancer disseminationQuantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progressionUrokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivoPermanent phenotypic and genotypic changes of prostate cancer cells cultured in a three-dimensional rotating-wall vessel.The role of vascular endothelial growth factor in the tissue specific in vivo growth of prostate cancer cells.miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation.The role of PTEN in prostate cancer cell tropism to the bone micro-environment.Modulation of DNA damage-induced apoptosis by cell adhesion is independently mediated by p53 and c-Abl.Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer.BMP7, a putative regulator of epithelial homeostasis in the human prostate, is a potent inhibitor of prostate cancer bone metastasis in vivoAlendronate decreases orthotopic PC-3 prostate tumor growth and metastasis to prostate-draining lymph nodes in nude mice.Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model.Differential CARM1 expression in prostate and colorectal cancers.GAS6/AXL axis regulates prostate cancer invasion, proliferation, and survival in the bone marrow niche.Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells.Prostate cancer and bone: the elective affinities.Monoamine oxidase A mediates prostate tumorigenesis and cancer metastasis.Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro.Cadherin-11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts.The cancer-related Runx2 protein enhances cell growth and responses to androgen and TGFbeta in prostate cancer cells.A novel method for monitoring tumor proliferation in vivo using fluorescent dye DiDAndrogen depletion up-regulates cadherin-11 expression in prostate cancer.PDGF upregulates Mcl-1 through activation of β-catenin and HIF-1α-dependent signaling in human prostate cancer cells.A radiolabeled nonapeptide probe targeting PC-3 cells and bone metastases of prostate cancer in mice.A multiplex assay to measure RNA transcripts of prostate cancer in urine.Molecular markers and determinants of prostate cancer metastasis.Bone Metastasis of Prostate Cancer Can Be Therapeutically Targeted at the TBX2-WNT Signaling Axis.GAS6 receptor status is associated with dormancy and bone metastatic tumor formationHuman prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrowLoss of let-7 microRNA upregulates IL-6 in bone marrow-derived mesenchymal stem cells triggering a reactive stromal response to prostate cancer.Chemopreventive and chemotherapeutic effects of genistein, a soy isoflavone, upon cancer development and progression in preclinical animal modelsBlockade of transforming growth factor-beta (TGFβ) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell lineLack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells.
P2860
Q21090839-7FCBB6E4-7230-460F-ACB5-0BA6D6E280A7Q24292232-E4202CAC-EAA8-4D6B-9C34-53EFAA1CFF9FQ24616262-C28AE866-BC15-4F0D-B0F0-5875992FAC35Q24633279-9321232D-3554-4DBA-9164-BF9C69E5E54AQ24650806-1D9D4E24-1AF2-4946-905C-F344D5DB281FQ27024775-4C7324C4-98C6-4E12-B637-747000AA746FQ27309083-65314561-567E-449B-B347-88A1673A8C65Q28286300-E0C82F04-8F66-4139-8240-A6BE5275FAB5Q28350698-A0F901B4-8C30-4321-9931-099AC3D469D1Q30307433-2AB59DC0-4027-4347-AB1D-3D8F5C31CF3BQ30307781-CD45EDCF-F14E-403A-8C01-A0EB5B3CD9CCQ30423329-16A0C106-0E7C-4AED-B60F-D566C4AB86FDQ30443138-5755A676-7CDC-4DDB-9702-E54895FC258FQ30450695-8081E07C-6173-49F3-84D3-B9F58EAB5EF2Q30453862-2165B980-AD87-4DBB-A709-CC46C23AFAB3Q33295288-36A00C15-3A43-49A0-8D72-B9E8634616ABQ33326045-3042BF75-C2D2-4E12-A246-AA53618ECDEEQ33548724-07EAC5EA-AB39-4933-8EA9-D139449CE6E2Q33576367-6076A7B3-B60D-46CB-BEEB-239D201196BDQ33622570-A5F3023A-0DA3-4BDF-B5A4-268447A1EEEEQ33645250-FA371B46-2400-46A5-B102-6C494D665B93Q33757791-613BCAE7-AFD7-4050-892C-5111C8DA2CFDQ33808309-C37A95D0-5F6D-4155-8069-A2DFF444743DQ33946560-D6DA73A4-536E-4C4D-8D1A-FD9A30FBD248Q34072879-8868C7D4-4345-4138-9447-D71442B58D8AQ34078444-7C2EFB22-5C53-4EF1-9F53-36BD41FABFC6Q34084498-2D5D68A3-5830-4F5B-A747-06940B8BDD88Q34116435-23769482-AC06-4C24-B640-0B799F1FBB67Q34140712-EC3F00B8-6DC0-4100-BA0B-E5A5C22096DEQ34204255-A8E9122D-E234-42DA-B5CC-D5E0385C6E60Q34429720-9960261C-85C0-4AF6-B43A-857D70370E71Q34465689-D3CF20E1-71A9-4AD9-829B-0E4E7B0584C9Q34549787-009B5312-5081-4375-9C43-A695ED545B24Q34700694-43FFC1F1-AC1B-4C37-8AE9-429E1BDA0254Q34755120-02C84E58-BCE7-4FB1-ADFA-D6F764C84CC3Q34971771-F52E8CE4-1E69-4442-9C4E-6342A8DC089BQ35014332-2DD833FB-8F4A-4458-9FD5-105F5BCAA19FQ35024363-3BDB2694-294D-4D75-937E-A47A3E30AD45Q35570431-14018E8E-DF0B-4834-8C86-6999A67A0FDDQ35829355-D62BAB16-C161-4CDE-B438-6668C4C7098B
P2860
Establishing human prostate cancer cell xenografts in bone: induction of osteoblastic reaction by prostate-specific antigen-producing tumors in athymic and SCID/bg mice using LNCaP and lineage-derived metastatic sublines.
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Establishing human prostate ca ...... e-derived metastatic sublines.
@ast
Establishing human prostate ca ...... e-derived metastatic sublines.
@en
type
label
Establishing human prostate ca ...... e-derived metastatic sublines.
@ast
Establishing human prostate ca ...... e-derived metastatic sublines.
@en
prefLabel
Establishing human prostate ca ...... e-derived metastatic sublines.
@ast
Establishing human prostate ca ...... e-derived metastatic sublines.
@en
P2093
P2860
P1476
Establishing human prostate ca ...... e-derived metastatic sublines.
@en
P2093
C F Murphy
G N Thalmann
P2860
P304
P356
10.1002/(SICI)1097-0215(19980911)77:6<887::AID-IJC15>3.0.CO;2-Z
P577
1998-09-01T00:00:00Z